An NH2-terminal truncated cytochrome P450 CYP3A4 showing catalytic activity is present in the cytoplasm of human liver cells

被引:0
|
作者
Songhee Jeon
Keon-Hee Kim
Chul-Ho Yun
Boo-Whan Hong
Yoon-Seok Chang
Ho-Seong Han
Yoo-Seok Yoon
Won-Bum Choi
Soyun Kim
Ai-Young Lee
机构
[1] Dongguk University School of Medicine,Department of Dermatology
[2] Goyang 410-773,Department of General Surgery
[3] Korea.,Department of Internal Medicine
[4] Research Institute of Biotechnology,Department of General Surgery
[5] Medical Science Research Center,Department of Internal Medicine
[6] Dongguk University,undefined
[7] Goyang 410-773,undefined
[8] Korea.,undefined
[9] School of Biological Sciences and Technology,undefined
[10] Chonnam National University,undefined
[11] Gwangju 500-757,undefined
[12] Korea.,undefined
[13] Eulji University School of Medicine,undefined
[14] Seoul 139-872,undefined
[15] Korea.,undefined
[16] Bundang Hospital,undefined
[17] Seoul National University College of Medicine,undefined
[18] Seongnam 463-707,undefined
[19] Korea.,undefined
[20] Bundang Hospital,undefined
[21] Seoul National University College of Medicine,undefined
[22] Seongnam 463-707,undefined
[23] Korea.,undefined
[24] Dongguk University School of Medicine,undefined
[25] Goyang 410-773,undefined
[26] Korea.,undefined
来源
Experimental & Molecular Medicine | 2008年 / 40卷
关键词
cytochrome P-450 CYP3A; cytoplasm; enzymology; microsomes, liver;
D O I
暂无
中图分类号
学科分类号
摘要
Cytochrome P450 3A4 (CYP3A4), is the dominant human liver hemoprotein enzyme localized in the endoplasmic reticulum (ER), and is responsible for the metabolism of more than 50% of clinically relevant drugs. While we were studying CYP3A4 expression and activity in human liver, we found that anti-CYP3A4 antibody cross-reacted with a lower band in liver cytoplasmic fraction. We assessed the activities of CYP3A4 and its truncated form in the microsomal and cytoplasmic fraction, respectively. In the cytoplasmic fraction, truncated CYP3A4 showed catalytic activity when reconstituted with NADPH-cytochrome P-450 reductase and cytochrome b5. In order to determine which site was deleted in the truncated form in vitro, we transfected cells with N-terminal tagged or C-terminal tagged human CYP3A4 cDNA. The truncated CYP3A4 is the N-terminal deleted form and was present in the soluble cytoplasmic fraction. Our result shows, for the first time, that N-terminal truncated, catalytically active CYP3A4 is present principally in the cytoplasm of human liver cells.
引用
收藏
页码:254 / 260
页数:6
相关论文
共 50 条
  • [21] Clozapine and levomepromazine induce the cytochrome P450 isoenzyme CYP3A4, but not CYP1A1/2, in human hepatocytes
    Danek, P.
    Basinska-Ziobron, A.
    Daniel, W. A.
    Wojcikowski, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S927 - S927
  • [22] Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes
    Niwa, T
    Shiraga, T
    Takagi, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (09) : 1805 - 1808
  • [23] Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
    Agrawal, Vishal
    Choi, Ji Ha
    Giacomini, Kathleen M.
    Miller, Walter L.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10): : 611 - 618
  • [24] THE NH2-TERMINAL REGION OF RABBIT CYP2E1 IS NOT ESSENTIAL FOR INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE
    VOZNESENSKY, AI
    SCHENKMAN, JB
    PERNECKY, SJ
    COON, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) : 156 - 161
  • [25] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Danek, Przemyslaw J.
    Basinska-Ziobron, Agnieszka
    Wojcikowski, Jacek
    Daniel, Wladyslawa A.
    PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 303 - 308
  • [26] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Przemysław J. Danek
    Agnieszka Basińska-Ziobroń
    Jacek Wójcikowski
    Władysława A. Daniel
    Pharmacological Reports, 2021, 73 : 303 - 308
  • [27] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
  • [28] Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine - Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6
    Yumibe, N
    Huie, K
    Chen, KJ
    Snow, M
    Clement, RP
    Cayen, MN
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (02) : 165 - 172
  • [29] Effects of cytochrome (CYP) p450 3A4 inducers on CYP2B6 catalytic activity.
    Faucette, S
    Lindley, C
    Hawke, R
    Shord, S
    Clarke, M
    LeCluyse, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P10 - P10
  • [30] Evaluation of Luciferin-Isopropyl Acetal as a CYP3A4 Substrate for Human Hepatocytes: Effects of Organic Solvents, Cytochrome P450 (P450) Inhibitors, and P450 Inducers
    Li, Albert P.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1598 - 1603